You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / CE

Care for Patients With Hepatitis D Virus Infection: Expert Guidance for Primary Care Clinicians

  • Authors: Fabien Zoulim, MD, PhD; Juan Mendive, MD, PhD
  • CME / CE Released: 11/1/2022
  • Valid for credit through: 11/1/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    Nurses - 0.50 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for primary care physicians, nurse practitioners, and gastroenterologists.

The goal of this activity is for the learner to be better able to discuss the pathophysiology and disease burden of HDV worldwide, utilize current guidelines to recognize individuals at risk for developing hepatitis D virus (HDV) infection, and provide support for patients after their diagnosis.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Pathophysiology of HDV infection
    • Disease burden of HDV
    • Screening recommendations for HDV


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


Faculty

  • Fabien Zoulim, MD, PhD

    Professor of Medicine
    Hospices Civils de Lyon
    INSERM Unit 1052
    Lyon University
    Lyon, France

    Disclosures

    Fabien Zoulim, MD, PhD, has the following relevant financial relationships: 
    Consultant or advisor for: AiCuris; Aligos; Antios Therapeutics; Assembly Biosciences, Inc.; Bluejay Therapeutics
    Speaker or member of speakers bureau for: Gilead
    Research funding from: Assembly Biosciences, Inc.; Beam Therapeutics; Johnson & Johnson; Viravaxx

  • Juan Mendive, MD, PhD

    Family Physician
    La Mina Primary Care Academic Centre Catalan Health Institute
    University of Barcelona
    Barcelona, Spain

    Disclosures

    Juan Mendive, MD, PhD, has the following relevant financial relationships: 
    Consultant or advisor for: Reckitt
    Other: Participant in educational activity for Kyowa Kirin

Editor

  • Gillian Griffith, BA (Mod), MA

    Medical Education Director, WebMD Global, LLC

    Disclosures

    Gillian Griffith, BA (Mod), MA, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance

    Disclosures

    Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

Developed through a partnership between Medscape and The European Society for Primary Care Gastroenterology.



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Nurses

  • Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

Care for Patients With Hepatitis D Virus Infection: Expert Guidance for Primary Care Clinicians

Authors: Fabien Zoulim, MD, PhD; Juan Mendive, MD, PhDFaculty and Disclosures

CME / CE Released: 11/1/2022

Valid for credit through: 11/1/2023

processing....

Educational Impact Challenge

The goal of this activity is for the learner to be better able to discuss the pathophysiology and disease burden of HDV worldwide, utilize current guidelines to recognize individuals at risk for developing hepatitis D virus (HDV) infection, and provide support for patients after their diagnosis.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.